Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20669965rdf:typepubmed:Citationlld:pubmed
pubmed-article:20669965lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:20669965lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:20669965pubmed:issue16lld:pubmed
pubmed-article:20669965pubmed:dateCreated2010-8-19lld:pubmed
pubmed-article:20669965pubmed:abstractTextIn this study, we investigated the anticancer properties of methoxy-substituted nickel(II)(salophene) derivatives. We demonstrated that the most active complex [NiII(3-OMe-salophene)] is not necrotic in Burkitt-like lymphoma cells (BJAB) and human B-cell precursor cells (Nalm-6). [NiII(3-OMe-salophene)] inhibited proliferation and induced apoptosis in a concentration dependent manner, giving evidence for the involvement of CD95 receptor-mediated, extrinsic pathway. Furthermore, [NiII(3-OMe-salophene)] overcame vincristine drug resistance in BJAB and Nalm-6 cells.lld:pubmed
pubmed-article:20669965pubmed:languageenglld:pubmed
pubmed-article:20669965pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20669965pubmed:citationSubsetIMlld:pubmed
pubmed-article:20669965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20669965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20669965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20669965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20669965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20669965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20669965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20669965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20669965pubmed:statusMEDLINElld:pubmed
pubmed-article:20669965pubmed:monthAuglld:pubmed
pubmed-article:20669965pubmed:issn1520-4804lld:pubmed
pubmed-article:20669965pubmed:authorpubmed-author:LeeSoo-YoungS...lld:pubmed
pubmed-article:20669965pubmed:authorpubmed-author:GustRonaldRlld:pubmed
pubmed-article:20669965pubmed:authorpubmed-author:WölflStefanSlld:pubmed
pubmed-article:20669965pubmed:authorpubmed-author:SchefflerHeik...lld:pubmed
pubmed-article:20669965pubmed:authorpubmed-author:ProkopAramAlld:pubmed
pubmed-article:20669965pubmed:authorpubmed-author:FriasCorazonClld:pubmed
pubmed-article:20669965pubmed:authorpubmed-author:HilleAnnegret...lld:pubmed
pubmed-article:20669965pubmed:authorpubmed-author:KaterBenjamin...lld:pubmed
pubmed-article:20669965pubmed:authorpubmed-author:BonitzkiBirgi...lld:pubmed
pubmed-article:20669965pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20669965pubmed:day26lld:pubmed
pubmed-article:20669965pubmed:volume53lld:pubmed
pubmed-article:20669965pubmed:ownerNLMlld:pubmed
pubmed-article:20669965pubmed:authorsCompleteYlld:pubmed
pubmed-article:20669965pubmed:pagination6064-70lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:meshHeadingpubmed-meshheading:20669965...lld:pubmed
pubmed-article:20669965pubmed:year2010lld:pubmed
pubmed-article:20669965pubmed:articleTitle[NiII(3-OMe-salophene)]: a potent agent with antitumor activity.lld:pubmed
pubmed-article:20669965pubmed:affiliationDepartment of Pediatric Oncology/Hematology, University Medical Center Charite, Berlin, Germany.lld:pubmed
pubmed-article:20669965pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20669965pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed